71 results
Page 2 of 4
6-K
EX-99.3
o445i5lzail35g9g 2m4
5 Mar 15
Current report (foreign)
12:00am
6-K
EX-99
hiptjp
9 Feb 15
2015 Annual General Meeting of Shareholders
12:00am
6-K
EX-99
llywwuk0a
5 Nov 14
BioLineRx Announces Successful Final Results of
12:00am
6-K
EX-99
656kgnr
21 Aug 14
BioLineRx Receives Notice of Allowance for US Patent on BL-7010
12:00am
6-K
EX-99
wz6x49gei 0s
16 Jul 14
BioLineRx Announces Results from
12:00am
424B2
01pg2b 7qf
13 Jun 14
Prospectus for primary offering
12:00am
6-K
EX-1
caev ruqz
11 Jun 14
Current report (foreign)
12:00am
F-3
sw87eh9dq0mi s7
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-99
b4c16y18 43flemt
10 Mar 14
BioLineRx Completes Dose Escalation Stage of Phase 1/2 Study
12:00am
424B5
wd1u 5eioafy7gf4
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
lwrw63crngchg9ldys
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
5o026t74p1dyt91q yew
3 Mar 14
Current report (foreign)
12:00am
6-K
EX-99
jt6z63lgl
18 Dec 13
Current report (foreign)
12:00am
6-K
EX-99
mxu471na 0je6hkkhv
4 Nov 13
BioLineRx Receives Regulatory Approval to Commence
12:00am
6-K
EX-99
8eyp07
24 Sep 13
BioLineRx Announces Regulatory Submission for Phase
12:00am
424B3
82no7hotusijq
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
mwkvwg
30 Apr 13
Current report (foreign)
12:00am
6-K
EX-99
mdeab n8gw
20 Mar 13
Current report (foreign)
12:00am